| Bioactivity | KKJ00626 is an inhibitor for Hepatitis B virus (HBV) with an IC50 of 0.12~0.23 μM. KKJ00626 inhibits the interaction between HBV core protein and the surface protein PreS region, prevents the maturation and secretion of HBV particles, and exhibits antiviral efficacy[1]. |
| CAS | 51646-17-4 |
| Formula | C7H8N4S |
| Molar Mass | 180.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Asif-Ullah M, et al., Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virus. Antiviral Res. 2006 Jun;70(2):85-90. |